SHAUWNEY KITTINGER: Open Payments
NPI 1528583069 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 12 payments from 8 companies in 2025. Trend: 2023 $53 · 2024 $147 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Regeneron Healthcare Solutions, Inc. | 3 | $44 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| GENZYME CORPORATION | 1 | $16 |
| United Therapeutics Corporation | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: DUPIXENT, FASENRA, NUCALA, DYSPORT, Hillrom - Vest System Model 105 Home Care, Tyvaso, Adempas, BREZTRI.
Industry payments across IN — which companies pay providers there.
